PositoAI
a positivity index
Home Explore Actions Flows Indices News Watchlist Compare PosiDemy Screeners Insights
PosiFunda · Fundamentals

Absci Corporation

PosiFunda Ratios Only on PositoAI

PositoAI's own ratios from Absci Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.

What stands out

  • Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.

Where $100 of sales goes

$4,579Operating costs$7.5Interest$4,114Net loss

Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.

Cash quality

Profit Cash Ratio

—

Loss-making or profit too small

Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.

Self-Funding Ratio

-97.0×

Over the last 3 years operating cash was negative while the company kept spending on investment (capex).

Lower than 81% of Healthcare companies in United States.

Cash Locked Ratio

—

Data incomplete

Growth quality

Steadiness Ratio

0/3 · 1/3

Sales grew in 0 of the last 3 years; profit grew in 1 of 3.

Less steady than 86% of Healthcare companies in United States.

Growth Efficiency Ratio

—

Sales fell 51%

Sales fell 51% in 3 years, so extra profit per extra sales cannot be measured.

Asset Productivity Ratio

-51% / -33%

In 3 years sales changed by -51% while total assets changed by -33%. Assets grew faster than sales.

Balance-sheet strength

Debt Due Cover Ratio

-106.4×

Operating cash was negative last year, while some debt falls due within a year.

Lower than 84% of Healthcare companies in United States.

Cash Cushion Ratio

+9%

Cash, after subtracting all debt, equals 9% of its market value (net cash).

Lower than 51% of Healthcare companies in United States.

Tangible Assets Ratio

81%

Of every $100 the company owns, $81 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.

More tangible than 50% of Healthcare companies in United States.

Tangible Net Worth Ratio

78%

Of every $100 of net worth, $78 is tangible; the rest is goodwill and other intangibles, often from buying other companies.

More tangible than 60% of Healthcare companies in United States.

Shareholders

Shareholder Slice Ratio

+64%

Share count rose 64% in 3 years, so each share's slice of the company became smaller.

Bigger rise in share count than 61% of Healthcare companies in United States.

Standard fundamentals

P/E, P/B, ROE, debt, growth and more (13)

Absci Corporation made a loss over the last year. Absci Corporation owes $0.08 for every $1 it owns. Absci Corporation made a loss in each of the last two years.

Compared with Healthcare companies in United States · latest annual results Dec 2025.

P/E ratio

Loss

Absci Corporation made a loss over the last year, so its P/E ratio is not meaningful.

P/B ratio

6.53

The share price is 6.53 times Absci Corporation's book value per share, higher than 78% of Healthcare companies in United States.

Market cap

$1.6 B

The total market value of all of Absci Corporation's shares at today's price (share price × number of shares), larger than 70% of Healthcare companies in United States. PosiCap size class: Meso Cap.

Net worth (book value)

$246 M

What Absci Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).

Book value per share

$1.43

Net worth divided by the number of shares. The share price of $9.37 is 6.5 times this, which is the P/B above.

Return on equity (ROE)

-57.7%

Absci Corporation lost 57.7% of its shareholders' money over the last year, lower than 55% of Healthcare companies in United States.

Owes vs Owns

0.08×

Absci Corporation owes $0.08 for every $1 it owns (low), lower than 89% of Healthcare companies in United States.

Dividend yield

None

Absci Corporation does not currently pay a dividend.

Revenue growth

-38%

Revenue fell 38% in the year to Dec 2025, and shrank 21% a year on average over 3 years.

Profit growth

Loss

Absci Corporation made a loss in each of the last two years.

Profit margin

-4113.7%

Absci Corporation lost $4114 for every $100 of revenue.

Interest cover

Not covered

Absci Corporation's operating profit did not cover its interest costs in the year to Dec 2025.

Cash vs debt

Net cash

Absci Corporation held $139 M more cash than debt (net cash) at Dec 2025.

Questions

How is P/B calculated on PositoAI?

P/B is market cap divided by net worth from the latest balance sheet. For Absci Corporation: $1.6 B ÷ $246 M (30 Jun 2026) = 6.5.

What is Absci Corporation's return on equity?

Absci Corporation lost 57.7% of its shareholders' money over the last year, lower than 55% of Healthcare companies in United States.

How much does Absci Corporation owe compared with what it owns?

Absci Corporation owes $0.08 for every $1 it owns (low), lower than 89% of Healthcare companies in United States.

Does Absci Corporation pay a dividend?

No. Absci Corporation does not currently pay a dividend.

Is Absci Corporation's revenue growing?

Revenue fell 38% in the year to Dec 2025, and shrank 21% a year on average over 3 years.

Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.